Supreme Court: Generic makers cannot be sued for drug designs

A 5-4 Supreme Court ruling on Monday limits product liability claims against the makers of generic drugs. A state law allowing the claims does not take precedence over federal laws that require generics to be the same and carry the same labeling as prescription drugs, Justice Samuel Alito wrote in the majority opinion.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal, The · Politico (Washington, D.C.) · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA